TheProfitWatch

APM - Aptorum Group Limited Class A Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.4 -0.09 (-6.43%) --- --- -0.03 (-2.48%) 0.0 (0.0%) -0.1 (-7.09%) 0.0 (0.0%) -0.05 (-3.45%)

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Category: /stock/categories/na
Market Period: Market

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:
0.0
VWAP:
1.31
RVol:

Events

Period Kind Movement Occurred At

Related News